Prospective Multicenter Study of the Impact of Oncotype DX Colon Cancer Assay Results on Treatment Recommendations in Stage II Colon Cancer Patients

PURPOSE. The Oncotype DX colon cancer assay is a clinically validated predictor of recurrence risk in stage II colon cancer patients. This prospective study evaluated the impact of recurrence score (RS) results on physician recommendations regarding adjuvant chemotherapy in T3, mismatch repair-profi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Srivastava, Geetika, Renfro, Lindsay A., Behrens, Robert J., Lopatin, Margarita, Chao, Calvin, Soori, Gamini S., Dakhil, Shaker R., Mowat, Rex B., Kuebler, J. Philip, Kim, George, Mazurczak, Miroslaw, Lee, Mark, Alberts, Steven R.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AlphaMed Press 2014
Onderwerpen:
Gastrointestinal Cancer
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4012966/
https://ncbi.nlm.nih.gov/pubmed/24710310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0401
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items